Market closed· · GBp · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Judges Scientific PLC (JSCIF) reported a sharp first-half decline with adjusted EPS down 72%, yet improving order intake and a 10% dividend hike signal cautious optimism for a Q4-weighted recovery.
Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying...
Despite a challenging year marked by US funding cuts, Judges Scientific PLC (JSCIF) showcases resilience with strong cash generation and a disciplined acquisition strategy.
Judges Scientific is back in focus after recent research cut a key price target by £23.00 to 2,300 GBp, even as the central Fair Value estimate of £60.63 stayed unchanged. Analysts are using these reduced targets to reset what they are comfortable assuming for long term earnings multiples and required returns, which is why you are seeing both bullish and bearish takes on the same move. As you read on, you will see how to interpret these shifting targets and keep track of the story as it...
What Changed in the Latest Judges Scientific Price Target Judges Scientific has just seen its fair value estimate move from £67.36 to £60.63, a cut of about £6.70 per share, as analysts plug softer revenue expectations into their models. The revenue outlook has shifted from a 3.71% decline to a 4.42% decline, and together with a slightly higher discount rate of 9.26% versus 9.11%, that points to a more cautious view of the balance between risk and potential reward. Stay with this article to...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.